Please note, this OEL/ADE monograph also applies to Prasterone sulfate (CAS RN 651-48-9), Prasterone acetate (CAS RN 853-23-6), Sodium prasterone sulfate (CAS RN 1099-87-2), Sodium prasterone sulfate dihydrate (CAS RN 78590-17-7), and Prasterone enanthate (CAS RN 23983-43-9). Prasterone is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. It is also taken as a supplement for a variety of unsubstantiated indications including schizophrenia, improving appearance of older people’s skin, and improving ability to achieve an erection in men with sexual dysfunction. Prasterone has also shown promise in improving symptoms of systemic lupus erythematosus.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Prasterone, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.